Streptococcal heme binding protein (Shp) is involved in the process of heme acquisition in group A Streptococcus (GAS). However, no research thus far has examined the contribution of Shp to the virulence of GAS. To this end, we generated an isogenic strain lacking the shp gene ( shp) and its complemented strain ( shp-c) using the parent strain MGAS5005 (WT). Deletion of shp increased survival rates and neutrophil recruitment and reduced skin lesion sizes and GAS loads in the blood and the liver, lung, kidney and spleen in subcutaneous infections of mice. These results indicate that Shp significantly contributes to the skin and systemic invasion of GAS. The growth of the shp mutant was significantly slower than MGAS5005 and shp-c than in non-immune human blood and in incubation with isolated rat neutrophils. Microarray transcriptional analyses found no alteration in expression of virulence genes, indicating that the phenotype of the shp mutant was directly linked to the lack of Shp. The findings indicate that Shp significantly contributes to GAS skin invasion, systemic infection and virulence and that these contributions of Shp are mediated by the effects of Shp on systemic GAS growth and neutrophil responses.
INTRODUCTION
Group A Streptococcus (GAS) is responsible for diverse human infections that range from mild pharyngitis and impetigo to severe invasive infections. In addition, acute post streptococcal glomerulonephritis, acute rheumatic fever and rheumatic heart disease may occur several weeks to several months after a group A streptococcal infection. The World Health Organization (WHO) reports over 616 million cases of GAS pharyngitis and more than 1.78 million new cases of severe GAS disease per year (Walker et al. 2014) . Thus, despite important advances in modern medicine and hygiene, GAS remains a very dangerous pathogen that accounts for over half a million deaths per year worldwide, thus contributing to enormous numbers of casualties.
GAS pharyngitis, which is common among children and adolescents, is typically treated with penicillin. However, GAS isolates with a high-level of resistance to macrolide antibiotics frequently occur (Silva-Costa et al. 2015; Magnussen et al. 2016; Michos et al. 2016) . Thus, more elaborate studies on GAS pathogenesis and more effective treatments for GAS infections are needed. A large number of GAS virulence factors, including M protein, hyaluronic capsule, complement inhibitor, C5a peptidase, hemolysins, SpeB and DNases, are known to influence the processes of adhesion and colonization, and innate immune resistance, as well as the capacity of GAS to facilitate tissue barrier degradation and dissemination within the human host (Collin and Olsen 2001; Fernie-King et al. 2001; Caswell et al. 2010; Cole et al. 2010; Chang et al. 2011; Flaherty et al. 2015; Uchiyama et al. 2015) . Accordingly, it is crucial to uncover the contributions of such virulence factors to specific disease processes because it will provide a basis for targeted therapeutic intervention.
Iron is essential for the growth and survival of most bacterial pathogens, including GAS and it is vital for virulence in many bacteria. Host heme is the primary source of iron for GAS (Rouault 2004; Wilks and Burkhard 2007; Cassat and Skaar 2013; Sheldon and Heinrichs 2015) . The heme acquisition machinery of GAS consists of a streptococcal hemoprotein receptor (Shr), a streptococcal heme binding protein (Shp) and an ATP-binding cassette transporter (HtsABC). Shr extracts heme from hemoglobin, and Shp efficiently transfers it from Shr to HtsA, thus facilitating acquisition of an essential iron source for the bacterium (Liu and Lei 2005; Nygaard et al. 2006; Ran et al. 2010; Dahesh, Nizet and Cole 2012; Ge and Sun 2014) . Shp is a conserved protein expressed on the bacterial surface, and Shp-specific antibodies have been detected in the sera of convalescent patients with both invasive and pharyngeal infections, demonstrating that Shp is an antigenic protein (Lei et al. 2002) . The objective of this study was to determine whether Shp is necessary for GAS pathogenesis and if so, assess its function in GAS infections.
MATERIALS AND METHODS

Bacterial strains and growth conditions
MGAS5005 (GenBank accession number: NC-002737) was propagated in Todd-Hewitt broth (BD Bioscience) supplemented with 0.2% (w/v) yeast extract (Amresco) at 37
• C and 5% CO 2 .
MGAS5005 was regarded as the wild-type (WT) strain in this study. The bacteria were grown to logarithmic phase in THY (OD 600 = 0.5), pelleted, washed and resuspended in phosphatebuffered saline (PBS) at the desired concentration.
Construction of the shp mutant and its complemented strain
A strain carrying an in-frame allelic replacement of shp was created in MGAS5005 as previously described (Zhu et al. 2009 ). The primer sets used to polymerase chain reaction (PCR) amplify the upstream and downstream regions DNA flanking shp were as follows: shp up F (5 -TCG AGATCTGTTAGGCTACCTTGGTGAATTG-3 ) plus shp up R (5 -GTC TCGAGCTGCATACACAAGATTTGTCATTG-3 ) and shp down F (5 -AGCTCGAGGAAACAGACAATTCTCAAAATC-3 ) plus shp down R (5 -CTGGATCCTTGTCTGGAATGGCATGAGCTGTT-3 ). The underlined bases indicate introduced restriction sites. The PCR product was digested, and ligated to the pGRV vector at BgIII/BamHI and XhoI sites to yield the recombinant plasmid pGRV-shp. After two rounds of homologous recombination, the shp mutant was identified by PCR (the shp and shp amplicons are 876 bp and 426 bp, respectively) and sequencing. Deletion of shp did not disrupt the open reading frame. In addition, a plasmid carrying the shp gene (pGRV-shp) was introduced into the shp mutant via electroporation to construct a complemented strain ( shp-c) . The sequence of the shp-c strain is theoretically consistent with the WT strain.
Mouse infection assays
CD1 mice (4-5 weeks old) were purchased from the Heilongjiang University of Chinese Medicine. To determine survival rates, mice were subcutaneously inoculated in the back with 0.2 ml of 1.2 × 10 8 CFU GAS suspensions in PBS, and observed once a day for 15 days (n = 20). To determine bacterial loads in the blood and organs, mice were also subcutaneously inoculated in the back with 0.2 ml of 1.2 × 10 8 CFU of GAS strains, and the blood, spleens, livers, lungs and kidneys were collected 24 h post-inoculation (n = 6). Colony forming units (CFUs) were determined by plating blood and tissue homogenate at appropriate dilutions on THY agar plates. To determine skin lesion areas, mice were subcutaneously inoculated in the back with 0.2 ml of 1.9 × 10 8 CFU of GAS strains. The skin lesion areas were measured at 24 h post-inoculation (n = 15). In addition, the skin lesions were collected for histological analyses. All protocols were approved by the Institute's Ethics Committee of Harbin Medical University.
Histological analysis
Skin lesions were excised from mice at 24 h post-inoculation and fixed in 4% neutral-buffered formalin over 24 h. The skin samples were then dehydrated with ethanol, cleared with xylene and embedded in paraffin. The paraffin blocks were processed to obtain 5 μm sections, which were stained with hematoxylin and eosin (HE staining) or 1% crystal violet and neutral fuchsin (Gram staining) according to standard staining procedures.
Detection of myeloperoxidase activity
Entire skin lesions of mice infected with the WT strain, shp mutant or shp-c strain were excised and homogenized. The level of myeloperoxidase (MPO) activity (U/total) was determined using an MPO assay kit (Nanjing Jiancheng Bioengineering Institute) with the aid of a microplate reader (SpectraMax, n = 6).
In vivo competition assay of GAS strains
Mice were administered an equivalent number of the shp mutant and WT strain by peritoneal injection. At 0, 4, 8 and 24 h after inoculation, blood was taken from the hearts of the mice and bacteria were cultivated on THY plates. The shp gene was examined by PCR. For each assay, 50 colonies were identified to calculate the ratio of the shp mutant to the WT strain in the blood.
Growth of GAS in human blood
Heparinized venous blood samples were obtained from four healthy adult donors who had been screened and showed no resistance to GAS prior to the experiment. Overnight cultures of GAS were diluted to 2 × 10 4 CFU in 20 μl PBS and mixed with 500 μl of fresh human blood. The samples were incubated at 37
• C for 3 h with gentle agitation on a rotating mixer. For each sample, 50 μl of the mixture was spread onto THY plates to determine the CFUs at 0, 30, 60, 120 and 180 min after incubation. 
Phagocytosis assay
Measurements of GAS resistance to neutrophils-mediated killing in vitro were conducted using rat neutrophils that were isolated from 3 ml of circulating blood by using HISTOPAQUE-1083 (Sigma) . Overnight cultures of GAS were diluted, and mixed with 2 × 10 4 neutrophils in 1 ml PBS [multiplicity of infection (MOI) = 10:1]. The samples were incubated at 37
• C for 2 h with gentle agitation on a rotating mixer. For each sample, 50 μl of the mixture was spread onto THY plates to determine CFUs at 0, 30, 60 and 120 min after incubation.
Transcriptional microarray
RNA was extracted from mid-logarithmic phase GAS using a kit (PureLink R RNA Mini kit, Thermo Fisher) and then used for transcriptional analyses. A cDNA microarray was purchased from NimbleGen and used to compare changes in gene expression between the WT and shp deletion strains (A4282-00-01, http://www.nimblegen.com/products/exp/prokaryotic.html).
The microarray includes 192 000 probes, which can detect more than 1800 genes. The fluorescence value of each gene reflects its level of expression.
Statistical analysis
The log-rank test was used to analyze the survival rates of the mice. The data were analyzed by one-way analysis of variance (ANOVA) or two-way ANOVA with Newman-Keuls multiplecomparison posttest. All figures were plotted using GraphPad Prism version 6.0. P values < 0.05 were considered statistically significant.
RESULTS
The absence of Shp reduces GAS virulence
To determine whether Shp is required for virulence, mice were infected with various GAS strains and the survival rates of WT (parent strain MGAS5005) with a mutant strain lacking the shp gene (designated shp) and the complemented strain (designated shp-c) were compared. The survival rates were monitored once daily for 15 days. Mice infected with the shp mutant exhibited a significantly higher survival rate than those infected with the WT strain (Fig. 1) . Mortality was observed in WT-infected mice as early as 1 day post-infection. The % survival of the shp-infected mice at the end point was 85%, whereas a 25% survival rate was observed for the WT-infected mice (P < 0.01). There was no difference in the survival rates of the WT-infected and shp-c-infected mice. Thus, the absence of Shp clearly reduced the virulence of GAS in a mouse model of infection.
Shp contributes to skin invasion and bacterial persistence at the site of infection
We further assessed the contribution of Shp to subcutaneous infection by inoculating mice with 1.9 × 10 8 CFU of GAS strains.
The skin lesions of representative mice were photographed 24 h post-inoculation ( Fig. 2A ). Mice infected with the shp mutant showed milder inflammation than those infected with the WT and the shp-c strains. The lesion areas were measured (WT: 4.26 ± 0.30 cm 2 , shp-c: 4.37 ± 0.36 cm 2 , shp: 2.52 ± 0.18 cm 2 , Fig. 2B ). The mean lesion area of mice infected with the shp mutant was nearly 59% of that of mice infected with the WT strain (P < 0.001). The milder and smaller lesion size indicated the weakened virulence of the shp mutant. Next, inflammatory cells and bacteria in the skin lesion were observed via HE and Gram staining. Mice infected with the shp mutant exhibited a bounded abscess at the site of inoculation, which was quite different from the large lesions caused by the WT and shp-c strains (Fig. 3A-C) . This result supports the conclusion that the shp mutant is attenuated for skin invasion compared with the WT strain. More importantly, inflammatory cells (pink) surround most of the bacteria (blue) in mice infected with the shp mutant, whereas large numbers of bacteria in mice infected with the WT strain had spread to the subcutaneous muscular layer ( Fig. 3D and E) , indicating that the inflammatory cells blocked more effectively the spread of the shp mutant. Thus, the presence of Shp enhances skin invasion and inhibits bacterial clearance by inflammatory cells.
The histological results suggest a role for Shp in GAS resistance to host innate immune clearance. Thus, it was important to determine the activity of neutrophils at the site of skin infection. MPO is a major enzyme stored in neutrophil azurophilic granules that is released into the environment upon neutrophil activation. Therefore, release of MPO from neutrophils in response to GAS can serve as a gauge of neutrophil activity. The MPO activity of mice infected with the shp mutant (6.378 ± 0.747 U/total) was 1.5-fold higher than that of mice infected with the WT strain (4.122 ± 0.388 U/total, P < 0.05, Fig. 4 ). This indicates that neutrophils had higher activities against the shp mutant compared to the WT strain. Thus, it is reasonable to assume that neutrophils can kill the shp mutant more effectively, reducing the area and degree of severity of skin invasion. Thus, the presence of Shp promotes skin invasion and inhibits the activity of neutrophils, contributing to bacterial persistence at the site of infection.
Shp is required for systemic dissemination of GAS
It was necessary to analyze bacterial loads recovered from the systemic dissemination post-subcutaneous infection. Bacterial Figure 4 . MPO activity of mice infected with WT, shp and shp-c strains. The entire lesion was excised and homogenized to determine activity at 24 h post-GAS infection. * , P < 0.05; * * , P < 0.01, n = 6.
CFUs in the blood, livers, lungs, kidneys and spleens of mice were enumerated at 24 h post-infection. The logCFUs of mice infected with the shp mutant were lower than those of mice infected with the WT strain ( Fig. 5A-E) . The initial logCFUs of mice infected with the shp mutant were equal to that of mice infected with the WT strain at the skin inoculation site (Fig. 5F ).
Notably, the logCFUs recovered for the shp mutant from the lung, kidney and spleen were significantly fewer than for the WT strain. Such reduced dissemination is likely caused by the impaired virulence of the shp mutant. Complementation of the shp gene restored bacterial loads to the levels of the WT strain ( Fig. 5A-E) . These results suggest that Shp is required for systemic dissemination of GAS.
Shp is necessary for GAS survival in whole blood
To further investigate the mechanism of reduced shp mutant virulence, we first compared competition between the shp mutant and WT strain in vivo. At each time point, the shp gene was examined by PCR to calculate the ratio of the shp mutant to the WT strain in the blood. As shown in Fig. 6A , the percentage of the shp mutant compared to the WT strain was 35% at 4 h post-infection, decreasing to 25% at 8 h and 16% at 24 h. The percentage of the shp mutant decreased over time, demonstrating that the shp mutant became less competitive when it coexisted with the WT strain in vivo. It is reasonable to conclude that the loss of Shp will impact the survival of GAS in vivo.
It was also important to examine whether Shp contributes to the survival of GAS in human blood. When equivalent CFUs were inoculated into 500 μl fresh blood, the shp mutant Figure 5 . GAS survival in mouse blood and organs, as measured by colony numbers at 24 h post-infection. CD1 mice were subcutaneously inoculated in the back with 1.2 × 10 8 CFU of GAS strains. * , P < 0.05; * * , P < 0.01, n = 6. 
Figure 7.
Comparison of rat neutrophil phagocytosis of GAS. Rat neutrophils were isolated from circulating blood and were co-incubated with GAS (MOI = 10:1). At each time point, a 50-μl sample was collected and spread on THY plates to determine CFUs. Each column represents the average value of three measurements. * * , P < 0.01; * * * , P < 0.001.
exhibited a significant reduction in growth compared with the WT and complemented strains at 120 and 180 min after incubation (Fig. 6B) . The mean CFU of the shp mutant at 120 min was 4.38 × 10 5 (logCFU = 5.64), which was 33% of that of the WT strain (CFU = 1.32 × 10 6 , logCFU = 6.12). The CFU of the shp mutant at 180 min was 8.36 × 10 5 , which was 25% of that of the WT strain (CFU = 3.37 × 10 6 , logCFU = 6.53). Deletion of shp impairs the survival of GAS in the blood at the early stage of infection. In contrast, the complemented strain showed similar growth to WT at each time point.
Shp is required for GAS resistance to neutrophils
Further investigation of the role of Shp in innate immune responses was achieved via measurements of neutrophilmediated killing of GAS (Fig. 7) . Rat neutrophils were coincubated with the WT, shp or shp-c strains for 2 h. GAS grows slowly due to its inhibition by rat neutrophils, and this was especially true for the shp mutant. After 60 and 120 min of incubation, a significant difference between the shp mutant and WT strain regarding neutrophil-mediated killing was observed (60 min: WT vs shp, P < 0.001; 120 min: WT vs shp, P < 0.01). Thus, the shp mutant was less able to resist being killed by neutrophils. These results indicate that Shp may have an effect on neutrophil resistance at the early stage of infection.
shp deletion does not alter expression of important virulence factors
A microarray was used to investigate the mechanism of weakened virulence caused by shp deletion, comparing over 1800 genes between the shp mutant and the WT strain. However, expression of genes encoding common virulence factors, including emm, sibA, sclA, scpA, sic, slo, covS, hasA, sdaD2, mac, ska, saga, mga, speB, grab and rgg, was not notably altered after shp deletion (Fig. 8) . Thus, deletion of the shp gene did not alter expression of other virulence factors, and the weakened virulence observed is therefore not caused by other virulence factors but is instead caused by the loss of Shp.
DISCUSSION
As it is unclear how GAS escapes from the innate immune system and invades its host, our research was aimed at determining whether deletion of a component of the heme acquisition system would reduce the virulence of GAS. Shp was the first cell surface heme binding protein identified in gram-positive pathogens (Lei et al. 2002) , and we hypothesized that Shp may also be an important virulence factor. To date, this is the first work to demonstrate the direct effect of a shp deletion on GAS virulence. Our findings may provide valuable targets for future therapeutic or vaccine interventions to treat this globally important pathogen. In this study, we analyzed the growth characteristics of the shp mutant in THY medium (data not shown) and its survival when it competes with the WT strain in vivo. The shp mutant grew well in THY culture but was severely inhibited by the WT strain in vivo, demonstrating that the deletion strain lacks a survival advantage in the host. Our ensuing experiments also confirmed this conclusion.
The skin lesion area of mice infected with the shp mutant was 59% of that of mice infected with the WT strain, which suggests that Shp contributes to skin invasion. In addition, infection of the shp mutant resulted in increased release of MPO in the lesion, indicating that neutrophils exhibit higher activities against the shp mutant. Neutrophils are inflammatory cells that reach the infection site and react quickly. Thus, evasion of neutrophils is crucial to the survival, dissemination and infection of GAS. The results of skin infection assays demonstrated that Shp clearly enhances skin invasion and inhibits neutrophil activity, contributing to bacterial persistence at the site of infection. Furthermore, the bacterial loads recovered from systemic dissemination post-subcutaneous infection also support our assumption that Shp is required for GAS systemic dissemination.
Previous results have shown that Shp is expressed during human infections and that Shp elicits a strong humoral immune response in the sera of convalescent patients (Lei et al. 2002) . Loss of Shp resulted in attenuated growth in whole blood, as evidenced by a reduced growth rate of the shp mutant relative to the WT strain. We also hypothesized that the shp mutant would be more potently inhibited by neutrophils in the blood. To test this hypothesis, we assessed neutrophil-mediated killing and found the shp mutant to be less able to resist neutrophil killing. The reduced growth rate of the shp mutant in blood and the reduced resistance to neutrophils correlate with the reduced virulence observed in the mouse skin and systemic infection models. According to the results of microarray analysis, deletion of shp does not alter expression of other virulence factors; therefore, the reduced virulence observed is not caused by other virulence factors but rather by the absence of Shp. Previous research fully elucidated how GAS requires iron for growth in addition to the iron uptake mechanism of Shp (Rouault 2004; Wilks and Burkhard 2007; Cassat and Skaar 2013; Ge and Sun 2014; Sheldon and Heinrichs 2015) , and loss of Shp limits iron acquisition and thus reduces the virulence of GAS.
The metabolism and virulence of GAS are closely linked. It is also recognized that the selection of growth substrate is important and the transcriptional regulation of virulence genes, including virulence factors that are not needed to metabolize certain substrates, but are needed to resist host defenses, can be altered depending on the substrate used (Pancholi and Caparon 2016). It appears that Shp is one such factor. Our microarray results confirm that 15 of 18 genes involved in the carbohydrate metabolism of MGAS5005 belong to the lac operon (lac.1 and lac.2), which were significantly upregulated in the shp deletion mutant (data not shown). This is an intriguing finding that has not been previously reported. The impact on carbohydrate metabolism and the restriction of iron acquisition caused by shp deletion will influence GAS virulence in whole or in part. Similarly, although the relationship between the availability of carbohydrates and the production of M protein or SLO has been elucidated, the mechanisms underlying these observations remain unknown. Future research on Shp is likely to further our understanding of the link between metabolism and virulence.
